Milestone Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2019 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Milestone Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2019 to Q2 2024.
  • Milestone Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 8, 2024 was 53.3M shares, a 59.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 53.3M +19.9M +59.6% Aug 8, 2024 10-Q 2024-08-08
Q1 2024 53.1M +19.9M +59.7% Mar 21, 2024 10-K/A 2024-04-29
Q3 2023 33.5M -803K -2.34% Nov 13, 2023 10-Q 2023-11-13
Q2 2023 33.4M +3.37M +11.2% Aug 10, 2023 10-Q 2023-08-10
Q1 2023 33.3M +3.37M +11.3% Mar 29, 2023 10-K/A 2023-05-31
Q3 2022 34.3M +4.41M +14.8% Nov 10, 2022 10-Q 2022-11-10
Q2 2022 30M +165K +0.55% Aug 10, 2022 10-Q 2022-08-10
Q1 2022 29.9M +71.3K +0.24% Mar 21, 2022 10-K 2022-03-24
Q3 2021 29.9M +49.6K +0.17% Nov 4, 2021 10-Q 2021-11-12
Q2 2021 29.8M +5.14M +20.8% Aug 9, 2021 10-Q 2021-08-11
Q1 2021 29.8M +5.29M +21.5% Mar 5, 2021 10-K 2021-03-29
Q3 2020 29.8M +5.33M +21.8% Nov 6, 2020 10-Q 2020-11-13
Q2 2020 24.7M +215K +0.88% Aug 3, 2020 10-Q 2020-08-12
Q1 2020 24.6M Mar 3, 2020 10-K/A 2020-10-23
Q3 2019 24.5M Nov 1, 2019 10-Q 2019-11-13
Q2 2019 24.5M Jun 14, 2019 10-Q 2019-06-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.